Closed-Loop Linear Slide Design with Voice Coil Motor and Linear Encoder The V-308 is built on a closed-loop motorized linear slide, featuring an optical position sensor that delivers sub-nanometer ...

The real estate acquisition follows the company hitting a new low stock price in January, when Windtree Therapeutics announced a strategy to acquire smaller companies and stop its stock slide.

Mid Cap Biotechnology Analyst Joseph and European Pharmaceuticals Analyst Gordon, along with Dr. Hogarth, Prof of Medicine in Pulmonary & ...

Shares of ImmunityBio touched a 52-week low after the company received a refusal-to-file letter from the Food and Drug Administration for a supplemental biologics license application for ...

Sanders' draft slide surprised everyone -- one fan so much that he is suing the NFL for $100 million in punitive damages, "for the harm caused to the Plaintiff and the impact of the NFL's actions ...

Cash, cash equivalents and marketable securities totaled $16.9M as of March 31 compared with $23.2M as of December 31, 2024. Unity believes that current cash, cash equivalents and marketable ...

The global AI in Pathology Market, valued at US$87.2 million in 2024, is forecasted to grow at a robust CAGR of 26.5%, ...

Terms While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors.

In RIT’s biotechnology bachelor’s degree you’ll develop technologies for genetics, agriculture, pharmaceuticals, vaccine development, energy/ environment, forensics, and more. Hands on Experience: ...

Amazon CEO Andy Jassy says some customers are “stocking up” in advance of widespread tariffs planned by President Donald Trump. “Obviously, none of us knows exactly where tariffs will settle ...

One such contender is Syntis Bio, a Boston-based biotech firm working on an oral medication designed to replicate the effects of gastric bypass surgery without the need for invasive procedures.

Genmab Announces Financial Results for the First Quarter of 2024May 8, 2025 Copenhagen, Denmark; Interim Report for the First Quarter Ended March 31, 2025HighlightsEPKINLY® (epcoritamab) approved by ...